<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200408046993N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-26</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>The effect of total cystectomy surgery versus parietal cystectomy on the ovarian reservation</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of Ovarian Reservation in Women with Endometriosis under Total Cystectomy Compared to Partial Cystectomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-01-14</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>56</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/47165</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, in people before surgery, the concentration of antimullerin hormone is measured by ELISA method and after grouping endometriosis in them, by using simple randomization method with individual unit and by using the table of random numbers of people in  The two groups of partial and total cystectomy are operated on, and all patients are operated on by one surgeon to minimize the difference in surgical technique.</study_design>
      <phase>3</phase>
      <hc_freetext>Endometriosis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: In this group, total cystectomy surgery was performed in which patients underwent general anesthesia and endotracheal intubation in 30 degree Thunderrenberg condition and lithotomy, and carbon dioxide gas was opened by a 10 mm trocar with open method And 10 mm Hg pressure and under the supervision of a 10 mm rigid laparoscope inserted through the umbilical port and 2 other 5 mm ports created 2 cm above the iliac bone and a uterine manipulator placed inside the patient's uterus. If necessary, the Keldosak area was released, then the cyst was aspirated and emptied, and the adhesion between the cyst and the pelvic wall was released, and then the internal wall of the cyst was gently separated from the normal ovarian cortex by two atromatic pliers. In all patients, the presence of endometriosis was confirmed by pathology, and the antimullerin levels of the hormone were examined before and 3 months after the operation. Intervention 2: Intervention group 2: In this group, partial cystectomy surgery was performed. In this method, patients underwent general anesthesia and endotracheal intubation in 30 degree Thunderrenberg condition and in lithotomy status, and carbon dioxide gas by a 10 mm trocar with open method and pressure 10 mmHg under the supervision of a 10 mm rigid laparoscope inserted through the umbilical port, two other 5 mm ports created 2 cm above the iliac bone, and a uterine manipulator placed inside the patient's uterus. If necessary, the Keldosak area was released, then the cyst was aspirated and emptied, and the adhesion between the cyst and the pelvic wall was released. The umbilical cord remains the ovary. In all patients, the presence of endometriosis was confirmed by pathology, and the antimullerin levels of the hormone were examined before and 3 months after the operation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Atiyeh Javaheri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Sadoughi hospital, Ebne- Sina Ave., Yazd, Iran</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8915887857</zip>
        <telephone>+98 35 3822 4000</telephone>
        <email>a.javaheri@ssu.ac.ir</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Atiyeh Javaheri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Sadoughi hospital, Ebne- Sina Ave., Yazd, Iran</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8915887857</zip>
        <telephone>+98 35 3822 4000</telephone>
        <email>a.javaheri@ssu.ac.ir</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 20 to 40 years old
Serum level of anti-Müllerian hormone (AMH) over than 1 ng/mL
ٍEndometrioma cyst larger than 4 cm</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Pregnancy
Menstrual bleeding disorder
Endocrine disorders include thyroid disorder, hyperprolactinemia, or Cushing's syndrome
History of ovarian surgery and surgeries that have altered the anatomy of the pelvic cavity
The serum level of follicle stimulating hormone (FSH) around menopause
Suspicion of ovarian malignancies
Take oral contraceptive pills (OCPs) three months before surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N80.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Endometriosis of ovary</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: In this group, total cystectomy surgery was performed in which patients underwent general anesthesia and endotracheal intubation in 30 degree Thunderrenberg condition and lithotomy, and carbon dioxide gas was opened by a 10 mm trocar with open method And 10 mm Hg pressure and under the supervision of a 10 mm rigid laparoscope inserted through the umbilical port and 2 other 5 mm ports created 2 cm above the iliac bone and a uterine manipulator placed inside the patient's uterus. If necessary, the Keldosak area was released, then the cyst was aspirated and emptied, and the adhesion between the cyst and the pelvic wall was released, and then the internal wall of the cyst was gently separated from the normal ovarian cortex by two atromatic pliers. In all patients, the presence of endometriosis was confirmed by pathology, and the antimullerin levels of the hormone were examined before and 3 months after the operation.</i_keyword>
      <i_keyword>Intervention group 2: In this group, partial cystectomy surgery was performed. In this method, patients underwent general anesthesia and endotracheal intubation in 30 degree Thunderrenberg condition and in lithotomy status, and carbon dioxide gas by a 10 mm trocar with open method and pressure 10 mmHg under the supervision of a 10 mm rigid laparoscope inserted through the umbilical port, two other 5 mm ports created 2 cm above the iliac bone, and a uterine manipulator placed inside the patient's uterus. If necessary, the Keldosak area was released, then the cyst was aspirated and emptied, and the adhesion between the cyst and the pelvic wall was released. The umbilical cord remains the ovary. In all patients, the presence of endometriosis was confirmed by pathology, and the antimullerin levels of the hormone were examined before and 3 months after the operation.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The serum  level of anti-müllerian hormone. Timepoint: At the beginning of the study (Before intervention) and 3 months after the intervention (Cystectomy). Method of measurement: Eliza's method.</prim_outcome>
      <prim_outcome>The  serum CA125 level. Timepoint: At the beginning of the study (Before intervention). Method of measurement: Eliza's method.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-01-14</approval_date>
        <contact_name>Ethics committee of Yazd Shahid Sadoughi University of Medical Sciences</contact_name>
        <contact_address>School of Medicine, Shahid Sadoughi University of Medical Sciences, Shohaday-e-Gomnam Blvd., Alem Sq., Yazd, Iran Yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
